Skip to main content
search

Dr. Joshua Grill discusses A4 Study results in Alzforum

By August 21, 2018February 19th, 2019Carousel Slider, Commentary, In the News

This week Alzforum posted coverage from the Alzheimer’s Association International Conference, including UCI MIND Director Dr. Joshua Grill’s presentation of data from The A4 Study (Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease Study). In The A4 Study, a secondary prevention trial of late-onset Alzheimer’s disease, people with elevated amyloid had higher levels of memory complaints than those without elevated amyloid.

To read the full article, click here > 

Related posts:

  1. FDA Advisory Panel meeting held to consider potential approval of donanemab Today, the FDA convened its Peripheral and Central Nervous System Drugs Advisory Committee to review the data from pivotal clinical trials of donanemab, a monoclonal antibody against the beta amyloid protein that accumulates in the brain of people with Alzheimer’s disease. One of these trials was conducted at UCI MIND....
  2. MIND Matters | Quarterly Newsletter | Spring 2024 Message from the Director   Dear Friends of UCI MIND, Please enjoy the latest issue of MIND Matters from UCI MIND. In this Spring issue, we highlight a number of exciting updates about the impact UCI MIND investigators are having in the field. On the cover, post-doctoral fellow Dr. Claire...
  3. Celebrating Hispanic Heritage Month: Honoring Our Commitment to Alzheimer’s Research in Hispanic and Latino Communities This Hispanic Heritage Month, we proudly recognize the invaluable contributions of our faculty, staff, community partners, and supporters who are dedicated to addressing Alzheimer’s disease and related dementias in the Hispanic and Latino communities. Our mission to advance Alzheimer’s research is strengthened by the passion and collaboration of those working...
Close Menu